Janux Therapeutics, Inc. (JANX)
NASDAQ: JANX · IEX Real-Time Price · USD
13.80
-0.04 (-0.29%)
Aug 8, 2022 4:00 PM EDT - Market closed
Balance Sheet (Trailing)
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Quarter Ending | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 |
---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents
|
55.95 | 36.4 | 39.39 | 251.63 | 70.77 | 7.81 | - | - | - | 0.66 |
Short-Term Investments
|
306.07 | 339.38 | 348.12 | 142.57 | 0 | 0 | - | - | - | 0 |
Cash & Cash Equivalents
|
362.02 | 375.78 | 387.51 | 394.2 | 70.77 | 7.81 | 0 | 0 | 0 | 0.66 |
Cash Growth
|
411.55% | 4709.69% | - | - | - | 1087.39% | - | - | - | - |
Receivables
|
0 | 0 | 0 | 0.38 | 0.38 | 8 | - | - | - | 0 |
Other Current Assets
|
2.64 | 1.24 | 2.08 | 2.04 | 0.26 | 0.25 | - | - | - | 0 |
Total Current Assets
|
364.65 | 377.02 | 389.59 | 396.61 | 71.41 | 16.06 | - | - | - | 0.66 |
Property, Plant & Equipment
|
2.79 | 1.6 | 1.36 | 0.22 | 0.16 | 0.16 | - | - | - | 0.02 |
Other Long-Term Assets
|
1.15 | 1.21 | 0.14 | 0 | 0.26 | 0 | - | - | - | 0 |
Total Long-Term Assets
|
3.94 | 2.81 | 1.5 | 0.22 | 0.41 | 0.16 | - | - | - | 0.02 |
Total Assets
|
368.6 | 379.82 | 391.08 | 396.82 | 71.82 | 16.22 | - | - | - | 0.68 |
Accounts Payable
|
1.94 | 2.46 | 3.61 | 0.35 | 0.86 | 0.43 | - | - | - | 0.27 |
Deferred Revenue
|
4.65 | 5.86 | 7.1 | 7.89 | 8 | 8 | - | - | - | 0 |
Current Debt
|
0.15 | 0.19 | 0.21 | 0 | 0 | 0 | - | - | - | 4 |
Other Current Liabilities
|
5.77 | 4.28 | 1.54 | 0.96 | -1.96 | -5.25 | - | - | - | 0.36 |
Total Current Liabilities
|
12.52 | 12.8 | 12.47 | 9.21 | 6.89 | 3.18 | - | - | - | 4.63 |
Long-Term Debt
|
0 | 0 | 0.02 | 0 | 0 | 0 | - | - | - | 0 |
Other Long-Term Liabilities
|
- | 0.7 | 1.84 | 2.82 | 4.35 | 6.05 | - | - | - | - |
Total Long-Term Liabilities
|
0 | 0.7 | 1.86 | 2.82 | 4.35 | 6.05 | - | - | - | 0 |
Total Liabilities
|
12.52 | 13.5 | 14.33 | 12.03 | 11.24 | 9.23 | - | - | - | 4.63 |
Total Debt
|
0.15 | 0.19 | 0.24 | 0 | 0 | 0 | - | - | - | 4 |
Common Stock
|
418.47 | 414.01 | 410.72 | 408.01 | 0.25 | 0.1 | 0 | 0 | 0 | 0.01 |
Retained Earnings
|
-60.82 | -47.41 | -34 | -23.23 | -17.02 | -14.74 | - | - | - | -7.96 |
Comprehensive Income
|
-1.57 | -0.27 | 0.02 | 0.02 | 0 | 0 | - | - | - | 0 |
Shareholders' Equity
|
356.08 | 366.33 | 376.75 | 384.8 | -16.77 | -14.64 | - | - | - | -7.94 |
Total Liabilities and Equity
|
368.6 | 379.82 | 391.08 | 396.82 | -5.53 | -5.41 | 0 | 0 | 0 | -3.32 |
Net Cash / Debt
|
361.86 | 375.59 | 387.27 | 394.2 | 70.77 | 7.81 | 0 | 0 | 0 | -3.34 |
Net Cash / Debt Growth
|
411.33% | 4707.21% | - | - | - | - | - | - | - | - |
Net Cash Per Share
|
8.76 | 15.96 | 9.41 | 39.29 | 63.69 | 8.54 | - | - | - | -4.99 |
Working Capital
|
352.14 | 364.22 | 377.12 | 387.4 | 64.51 | 12.88 | - | - | - | -3.97 |
Book Value Per Share
|
8.62 | 15.57 | 9.16 | 38.35 | -15.09 | -15.99 | - | - | - | -11.87 |
Source: Financials are provided by
Nasdaq Data Link
and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).